uniQure (QURE) Treasury Shares (2015 - 2026)
uniQure (QURE) posted quarterly Treasury Shares of $2.5 million for Q2 2026, up 15.68% year-over-year from $2.2 million in Q2 2025, and down 6.83% quarter-over-quarter from $2.7 million in Q1 2026.
uniQure (QURE) Treasury Shares (2015 - 2026) Analysis & Trends
uniQure's Treasury Shares history runs 12 years deep, the most recent figure standing at $2.5 million for Q2 2026.
- In Q2 2026, Treasury Shares rose 15.68% year-over-year to $2.5 million; the TTM figure through Jun 2026 stood at $2.5 million (up 15.68% YoY), while the FY2025 annual figure was $2.4 million, up 44.31% from the prior year.
- Treasury Shares for Q2 2026 stood at $2.5 million, down from $2.7 million in the prior quarter.
- The five-year high for Treasury Shares was $2.7 million in Q1 2024, with the low at $1.7 million in Q4 2024.
- The 5-year median for Treasury Shares is $2.3 million (2023), against an average of $2.2 million.
- The sharpest annual moves came in 2022 and 2025: Treasury Shares soared 159.95% in 2022, then fell 27.73% in 2025.
- uniQure's Treasury Shares stood at $1.8 million in 2022, then rose by 24.5% to $2.3 million in 2023, then dropped by 26.69% to $1.7 million in 2024, then soared by 44.31% to $2.4 million in 2025, then grew by 4.69% to $2.5 million in 2026.
- Business Quant data shows QURE's Treasury Shares at $2.5 million in Q2 2026, $2.7 million in Q1 2026, and $2.4 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 36.40 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 5.08 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 2.72 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 92,219.00 |
| 10 | uniQure | 3.37 Bn | 3.37 Bn | 5.49 Mn | 2.51 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.51 Mn |
| Jun 30, 2026 | 2.51 Mn |
| Mar 31, 2026 | 2.69 Mn |
| Mar 31, 2026 | 2.69 Mn |
| Dec 31, 2025 | 2.40 Mn |
| Dec 31, 2025 | 2.40 Mn |
| Sep 30, 2025 | 2.29 Mn |
| Sep 30, 2025 | 2.29 Mn |
| Jun 30, 2025 | 2.17 Mn |
| Jun 30, 2025 | 2.17 Mn |
| Mar 31, 2025 | 1.96 Mn |
| Mar 31, 2025 | 1.96 Mn |
| Dec 31, 2024 | 1.66 Mn |
| Dec 31, 2024 | 1.66 Mn |
| Sep 30, 2024 | 1.98 Mn |
| Sep 30, 2024 | 1.98 Mn |
| Jun 30, 2024 | 2.56 Mn |
| Jun 30, 2024 | 2.56 Mn |
| Mar 31, 2024 | 2.71 Mn |
| Mar 31, 2024 | 2.71 Mn |